[Skip to Navigation]
Sign In

January 2022 - July 1883

Decade

Year

Issue

July 11, 2017, Vol 318, No. 2, Pages 105-210

In This Issue of JAMA

Highlights

Abstract Full Text
free access has audio
JAMA. 2017;318(2):105-107. doi:10.1001/jama.2016.13212
Original Investigation

Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial

Abstract Full Text
free access
JAMA. 2017;318(2):132-145. doi:10.1001/jama.2017.8036

This randomized clinical trial compares the effects on symptom remission of switching to bupropion, adding bupropion, or adding aripiprazole to baseline treatment among Veterans Affairs patients with antidepressant-resistant major depressive disorder.

Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone

Abstract Full Text
free access
JAMA. 2017;318(2):146-155. doi:10.1001/jama.2017.8040

This Swedish cohort study investigates whether treatment with alendronate is associated with reduced risk of hip fracture among older patients using oral glucocorticoids.

Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysis

Abstract Full Text
free access
JAMA. 2017;318(2):156-166. doi:10.1001/jama.2017.7967

This systematic review analyzes 10 randomized clinical trials comparing the effects of positive airway pressure (PAP) vs sham PAP in reducing cardiovascular outcomes or death among patients with sleep apnea.

Research Letter

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

Abstract Full Text
free access
JAMA. 2017;318(2):197-198. doi:10.1001/jama.2017.7156

This study assesses overall survival associated with electronic patient-reported symptom monitoring vs usual care during routine cancer treatment.

US Preventive Services Task Force

Recommendation Statement

Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Cardiovascular Risk Factors: US Preventive Services Task Force Recommendation Statement

Abstract Full Text
free access has audio
JAMA. 2017;318(2):167-174. doi:10.1001/jama.2017.7171

This Recommendation Statement from the US Preventive Services Task Force recommends that primary care professionals individualize the decision to refer adults without obesity and cardiovascular risk factors to behavioral counseling to promote healthful diet and physical activity (C recommendation).

Evidence Report

Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force

Abstract Full Text
free access
JAMA. 2017;318(2):175-193. doi:10.1001/jama.2017.3303

This Evidence Report and systematic review to support a 2017 US Preventive Services Task Force Recommendation Statement summarizes current evidence on benefits and harms of behavioral counseling for primary prevention of cardiovascular disease (CVD) in adults without known CVD risk factors.

Viewpoint

Reducing Excessive Use of Antipsychotic Agents in Nursing Homes

Abstract Full Text
JAMA. 2017;318(2):118-119. doi:10.1001/jama.2017.7032

This Viewpoint describes the structure and outcomes of a national initiative of the Centers for Medicare & Medicaid Services to reduce the use of antipsychotics in nursing homes.

Antiplatelet Therapy in Patients With Coronary Stents Undergoing Elective Noncardiac Surgery: Continue, Stop, or Something in Between?

Abstract Full Text
JAMA. 2017;318(2):120-121. doi:10.1001/jama.2017.7845

This Viewpoint discusses the management of antiplatelet therapy in patients with coronary stents undergoing elective noncardiac surgery.

Social Mission in Health Professions Education: Beyond Flexner

Abstract Full Text
JAMA. 2017;318(2):122-123. doi:10.1001/jama.2017.7286

This Viewpoint urges all medical and health professional training programs to make social mission a central curricular focus to help evenly distribute health care and to eliminate health disparities among patients who have little means and access to health care.

A Piece of My Mind

Stories Doctors Tell

Abstract Full Text
JAMA. 2017;318(2):124-125. doi:10.1001/jama.2017.5518
Editorial

Lessons Learned From the VA Augmentation and Switching Treatments for Improving Depression Outcomes (VAST-D) Study

Abstract Full Text
JAMA. 2017;318(2):126-128. doi:10.1001/jama.2017.8030

Does Obstructive Sleep Apnea Treatment Reduce Cardiovascular Risk?It Is Far Too Soon to Say

Abstract Full Text
JAMA. 2017;318(2):128-130. doi:10.1001/jama.2017.7966

Cardiovascular Risk Factor Control for All

Abstract Full Text
JAMA. 2017;318(2):130-131. doi:10.1001/jama.2017.7648
From the JAMA Network

Balancing Ischemic and Bleeding Risks of Prolonged Dual Antiplatelet Therapy

Abstract Full Text
has audio
JAMA. 2017;318(2):194-195. doi:10.1001/jama.2017.6698

This commentary discusses a study published in JAMA Cardiology that assessed the prognosis of cardiovascular and bleeding events associated with dual antiplatelet therapy continued beyond a year after coronary stenting.

Medical News & Perspectives

Starch-Based “Super Food” May Protect Against Variety of Diseases

Abstract Full Text
JAMA. 2017;318(2):112-114. doi:10.1001/jama.2017.5966

This Medical News article discusses research exploring the clinical potential of a chemically modified dietary starch to protect against type 1 diabetes and other diseases.

The JAMA Forum

Rethinking Rural Hospitals

Abstract Full Text
free access
JAMA. 2017;318(2):114-115. doi:10.1001/jama.2017.7535
News From the Centers for Disease Control and Prevention

Toxic Mushrooms in California

Abstract Full Text
JAMA. 2017;318(2):117. doi:10.1001/jama.2017.7990

Conception Without HIV Transmission

Abstract Full Text
JAMA. 2017;318(2):117. doi:10.1001/jama.2017.8053
Biotech Innovations

Total-Body PET Scanner Prototype Due Next Year

Abstract Full Text
JAMA. 2017;318(2):116. doi:10.1001/jama.2017.8300

Ex-FDA Chief Robert Califf, MD, Heads to Silicon Valley

Abstract Full Text
JAMA. 2017;318(2):116. doi:10.1001/jama.2017.8765

Spark Advances Gene Therapy for Inherited Vision Loss

Abstract Full Text
JAMA. 2017;318(2):116. doi:10.1001/jama.2017.8767
Poetry and Medicine

Ventricles

Abstract Full Text
JAMA. 2017;318(2):203. doi:10.1001/jama.2017.1778
JAMA Patient Page

Counseling on Healthy Living to Prevent Cardiovascular Disease in Adults Without Risk Factors

Abstract Full Text
free access
JAMA. 2017;318(2):210. doi:10.1001/jama.2017.8445
Comment & Response

Vaginal Fetal Fibronectin to Predict Spontaneous Preterm Birth

Abstract Full Text
JAMA. 2017;318(2):198-199. doi:10.1001/jama.2017.7133

Vaginal Fetal Fibronectin to Predict Spontaneous Preterm Birth—Reply

Abstract Full Text
JAMA. 2017;318(2):199-200. doi:10.1001/jama.2017.7137

Hemoglobin A1c as a Surrogate for Clinical Outcomes in Diabetes Studies

Abstract Full Text
JAMA. 2017;318(2):200. doi:10.1001/jama.2017.7222

Hemoglobin A1c as a Surrogate for Clinical Outcomes in Diabetes Studies—Reply

Abstract Full Text
JAMA. 2017;318(2):200-201. doi:10.1001/jama.2017.7225

Posing Causal Questions When Analyzing Observational Data

Abstract Full Text
JAMA. 2017;318(2):201. doi:10.1001/jama.2017.6227

Posing Causal Questions When Analyzing Observational Data—Reply

Abstract Full Text
JAMA. 2017;318(2):201-202. doi:10.1001/jama.2017.6235
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2017;318(2):109-110. doi:10.1001/jama.2016.13213
×